feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Xspray Pharma: Go-ahead from the Swedish MPA
Research Note
2018-06-21
12:08
Xspray has received a go-ahead to carry out the awaited clinical study with HyNap-Dasa.
MS
Mathias Spinnars
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans